Urological oncology has made dramatic advancements over the past five years concerning diagnostics, operative approach, instrumentation and pharmaceutical products. Dr Zargar offers the latest in diagnostics and therapeutics to patients with testicular, bladder, kidney and prostate cancer.
Diagnostic Imaging
The MRI machinery and techniques have progressed significantly over the past five years. This is particularly the case for prostate imaging where previously precise imaging methods were not available. Dr Zargar has a longstanding interest in this field and has published few manuscripts concerning the role of MRI in diagnosis of prostate cancer. He continues to be involved with research concerning MRI and prostate cancer. For patients with elevated PSA, he selectively offers prostate MRI imaging and real time MRI imaging for sampling specific areas of concern within the prostate gland.
Other imaging techniques include position emission topography (PET scan) which in combination with newer prostate cancer markers (PSMA) offer more advanced imaging however their true value is still to be determined.
The newer imaging techniques in combination with advanced 3D printing systems also allows for tissue and tumor reconstruction allowing for better conceptualization and planning of the surgical procedures. This has been particularly of value in complex kidney tumors where kidney preserving surgery is contemplated. Dr Zargar will discuss this with you if this is something that will aid in your treatment or something that you might be interested in.
Genomics
With the recent advances in whole genome sequencing and specific identification of genes involved in various aspects of urological cancer, many commercial multiplex gene panel tests have become available for clinical practice. Various urine and tissue gene panels are available for patients with kidney, bladder and prostate cancer. Such developments have and will allow for patients tailored specific treatment strategies and are another armament in development of precision personal medicine.Depending on your clinical scenario, Dr Zargar will discuss these with you as additional tools in helping tailoring the best care plan for your condition.
Pharmaceutical
Multiple novel agents, immunotherapy and targeted agents have been developed or are in latest phases of development for patients with urological malignancies. Dr Zargar works closely with the other members of multidisciplinary team and will offer you best therapy based on the latest available evidence or access to clinical trials based on the context of your clinical condition.
Surgery
Surgery still plays a primary role in the diagnosis and treatment of the majority of urological cancers. Doctor Zargar performs a wide range of oncological procedures. In the majority of the cases, the surgery is performed in a minimally invasive fashion and with the aid of robotic technology